avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Atf3
|
ENSMUSG00000026628.8 | activating transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Atf3 | mm10_v2_chr1_-_191183244_191183340 | -0.60 | 1.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_97417730 | 5.76 |
ENSMUST00000043077.7
|
Thrsp
|
thyroid hormone responsive |
chr4_-_122961173 | 5.14 |
ENSMUST00000030408.5
ENSMUST00000127047.1 |
Mfsd2a
|
major facilitator superfamily domain containing 2A |
chr19_+_39510844 | 4.97 |
ENSMUST00000025968.4
|
Cyp2c39
|
cytochrome P450, family 2, subfamily c, polypeptide 39 |
chr4_-_62087261 | 4.39 |
ENSMUST00000107488.3
ENSMUST00000107472.1 ENSMUST00000084531.4 |
Mup3
|
major urinary protein 3 |
chr9_-_48605147 | 4.34 |
ENSMUST00000034808.5
ENSMUST00000119426.1 |
Nnmt
|
nicotinamide N-methyltransferase |
chr3_-_81975742 | 4.33 |
ENSMUST00000029645.8
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr11_-_120661175 | 4.31 |
ENSMUST00000150458.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr2_+_67748212 | 4.11 |
ENSMUST00000180887.1
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr17_+_79626669 | 3.97 |
ENSMUST00000086570.1
|
4921513D11Rik
|
RIKEN cDNA 4921513D11 gene |
chr12_-_103657095 | 3.75 |
ENSMUST00000152517.1
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr10_+_127866457 | 3.48 |
ENSMUST00000092058.3
|
BC089597
|
cDNA sequence BC089597 |
chr11_+_83709015 | 3.48 |
ENSMUST00000001009.7
|
Wfdc18
|
WAP four-disulfide core domain 18 |
chr17_-_34000257 | 3.36 |
ENSMUST00000087189.6
ENSMUST00000173075.1 ENSMUST00000172760.1 ENSMUST00000172912.1 ENSMUST00000025181.10 |
H2-K1
|
histocompatibility 2, K1, K region |
chr13_+_4436094 | 3.34 |
ENSMUST00000156277.1
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr9_-_57683644 | 3.21 |
ENSMUST00000034860.3
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2 |
chr1_+_127729405 | 3.20 |
ENSMUST00000038006.6
|
Acmsd
|
amino carboxymuconate semialdehyde decarboxylase |
chr1_-_139608282 | 3.18 |
ENSMUST00000170441.2
|
Cfhr3
|
complement factor H-related 3 |
chr12_-_103657159 | 3.17 |
ENSMUST00000044159.6
|
Serpina6
|
serine (or cysteine) peptidase inhibitor, clade A, member 6 |
chr17_+_36942910 | 3.12 |
ENSMUST00000040498.5
|
Rnf39
|
ring finger protein 39 |
chr17_+_36943025 | 3.08 |
ENSMUST00000173072.1
|
Rnf39
|
ring finger protein 39 |
chr17_-_32917048 | 3.07 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr14_+_52824340 | 3.06 |
ENSMUST00000103648.2
|
Trav11d
|
T cell receptor alpha variable 11D |
chr9_+_44067072 | 3.04 |
ENSMUST00000177054.1
|
Usp2
|
ubiquitin specific peptidase 2 |
chr9_+_44066993 | 3.04 |
ENSMUST00000034508.7
|
Usp2
|
ubiquitin specific peptidase 2 |
chr19_-_40073731 | 3.04 |
ENSMUST00000048959.3
|
Cyp2c54
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
chr13_+_4434306 | 3.00 |
ENSMUST00000021630.8
|
Akr1c6
|
aldo-keto reductase family 1, member C6 |
chr7_-_14492926 | 2.99 |
ENSMUST00000108524.3
|
Sult2a7
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 7 |
chr5_-_87254804 | 2.98 |
ENSMUST00000075858.3
|
Ugt2b37
|
UDP glucuronosyltransferase 2 family, polypeptide B37 |
chr2_+_155276297 | 2.91 |
ENSMUST00000029128.3
|
Map1lc3a
|
microtubule-associated protein 1 light chain 3 alpha |
chr1_-_121332545 | 2.90 |
ENSMUST00000161068.1
|
Insig2
|
insulin induced gene 2 |
chr8_-_111630325 | 2.84 |
ENSMUST00000070004.3
|
Ldhd
|
lactate dehydrogenase D |
chr5_-_87091150 | 2.79 |
ENSMUST00000154455.1
|
Ugt2b36
|
UDP glucuronosyltransferase 2 family, polypeptide B36 |
chr19_-_4042165 | 2.79 |
ENSMUST00000042700.9
|
Gstp2
|
glutathione S-transferase, pi 2 |
chr1_-_13660476 | 2.79 |
ENSMUST00000027071.5
|
Lactb2
|
lactamase, beta 2 |
chr5_-_87591582 | 2.79 |
ENSMUST00000031201.7
|
Sult1e1
|
sulfotransferase family 1E, member 1 |
chr17_-_46487641 | 2.78 |
ENSMUST00000047034.8
|
Ttbk1
|
tau tubulin kinase 1 |
chr7_+_140763739 | 2.71 |
ENSMUST00000026552.7
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr7_-_25539950 | 2.70 |
ENSMUST00000044547.8
|
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr10_-_24101951 | 2.70 |
ENSMUST00000170267.1
|
Taar8c
|
trace amine-associated receptor 8C |
chr19_-_8218832 | 2.68 |
ENSMUST00000113298.2
|
Slc22a29
|
solute carrier family 22. member 29 |
chr13_-_23914998 | 2.67 |
ENSMUST00000021769.8
ENSMUST00000110407.2 |
Slc17a4
|
solute carrier family 17 (sodium phosphate), member 4 |
chr4_+_115299046 | 2.67 |
ENSMUST00000084343.3
|
Cyp4a12a
|
cytochrome P450, family 4, subfamily a, polypeptide 12a |
chr5_-_87337165 | 2.66 |
ENSMUST00000031195.2
|
Ugt2a3
|
UDP glucuronosyltransferase 2 family, polypeptide A3 |
chr15_-_98677451 | 2.63 |
ENSMUST00000120997.1
ENSMUST00000109149.2 ENSMUST00000003451.4 |
Rnd1
|
Rho family GTPase 1 |
chr19_+_12633303 | 2.61 |
ENSMUST00000044976.5
|
Glyat
|
glycine-N-acyltransferase |
chr19_-_44407703 | 2.52 |
ENSMUST00000041331.2
|
Scd1
|
stearoyl-Coenzyme A desaturase 1 |
chr3_+_63295815 | 2.52 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chrX_-_140543177 | 2.52 |
ENSMUST00000055738.5
|
Tsc22d3
|
TSC22 domain family, member 3 |
chr18_-_3281036 | 2.51 |
ENSMUST00000049942.6
ENSMUST00000139537.1 ENSMUST00000124747.1 |
Crem
|
cAMP responsive element modulator |
chr4_-_105109829 | 2.51 |
ENSMUST00000030243.7
|
Prkaa2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr9_-_86695897 | 2.47 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr19_+_12633507 | 2.47 |
ENSMUST00000119960.1
|
Glyat
|
glycine-N-acyltransferase |
chr13_-_64274962 | 2.47 |
ENSMUST00000039318.8
|
Cdc14b
|
CDC14 cell division cycle 14B |
chr1_+_88095054 | 2.41 |
ENSMUST00000150634.1
ENSMUST00000058237.7 |
Ugt1a7c
|
UDP glucuronosyltransferase 1 family, polypeptide A7C |
chr11_+_72435511 | 2.40 |
ENSMUST00000076443.3
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr2_-_62412219 | 2.39 |
ENSMUST00000047812.7
|
Dpp4
|
dipeptidylpeptidase 4 |
chr11_+_72435534 | 2.39 |
ENSMUST00000108499.1
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr8_-_24576297 | 2.38 |
ENSMUST00000033953.7
ENSMUST00000121992.1 |
Ido2
|
indoleamine 2,3-dioxygenase 2 |
chr2_+_162987330 | 2.35 |
ENSMUST00000018012.7
|
Sgk2
|
serum/glucocorticoid regulated kinase 2 |
chr10_-_88504073 | 2.35 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr10_+_128971191 | 2.35 |
ENSMUST00000181142.1
|
9030616G12Rik
|
RIKEN cDNA 9030616G12 gene |
chr2_-_5676046 | 2.34 |
ENSMUST00000114987.3
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr11_+_72435565 | 2.34 |
ENSMUST00000100903.2
|
Ggt6
|
gamma-glutamyltransferase 6 |
chr7_-_48843663 | 2.34 |
ENSMUST00000167786.2
|
Csrp3
|
cysteine and glycine-rich protein 3 |
chr17_+_35320529 | 2.33 |
ENSMUST00000105041.3
ENSMUST00000073208.5 |
H2-Q1
|
histocompatibility 2, Q region locus 1 |
chr19_-_7802578 | 2.32 |
ENSMUST00000120522.1
ENSMUST00000065634.7 |
Slc22a26
|
solute carrier family 22 (organic cation transporter), member 26 |
chr17_+_79614900 | 2.32 |
ENSMUST00000040368.2
|
Rmdn2
|
regulator of microtubule dynamics 2 |
chr5_-_87424201 | 2.30 |
ENSMUST00000072818.5
|
Ugt2b38
|
UDP glucuronosyltransferase 2 family, polypeptide B38 |
chr12_-_104865076 | 2.28 |
ENSMUST00000109937.1
ENSMUST00000109936.1 |
Clmn
|
calmin |
chr7_-_73537621 | 2.27 |
ENSMUST00000172704.1
|
Chd2
|
chromodomain helicase DNA binding protein 2 |
chr19_-_59076069 | 2.25 |
ENSMUST00000047511.7
ENSMUST00000163821.1 |
4930506M07Rik
|
RIKEN cDNA 4930506M07 gene |
chr10_-_88503912 | 2.24 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr3_-_39359128 | 2.22 |
ENSMUST00000056409.2
|
Gm9845
|
predicted pseudogene 9845 |
chr3_-_108017877 | 2.21 |
ENSMUST00000004140.4
|
Gstm1
|
glutathione S-transferase, mu 1 |
chr7_-_44496406 | 2.20 |
ENSMUST00000118515.1
ENSMUST00000138328.1 ENSMUST00000008284.8 ENSMUST00000118808.1 |
Emc10
|
ER membrane protein complex subunit 10 |
chr5_+_9100681 | 2.18 |
ENSMUST00000115365.1
|
Tmem243
|
transmembrane protein 243, mitochondrial |
chr10_+_62071014 | 2.17 |
ENSMUST00000053865.5
|
Gm5424
|
predicted gene 5424 |
chr3_-_107986360 | 2.17 |
ENSMUST00000066530.6
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr6_+_41302265 | 2.16 |
ENSMUST00000031913.4
|
Try4
|
trypsin 4 |
chr7_+_140845562 | 2.16 |
ENSMUST00000035300.5
|
Scgb1c1
|
secretoglobin, family 1C, member 1 |
chr11_-_78422217 | 2.15 |
ENSMUST00000001122.5
|
Slc13a2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
chr5_-_86926521 | 2.12 |
ENSMUST00000031183.2
|
Ugt2b1
|
UDP glucuronosyltransferase 2 family, polypeptide B1 |
chr4_+_42735545 | 2.12 |
ENSMUST00000068158.3
|
4930578G10Rik
|
RIKEN cDNA 4930578G10 gene |
chr11_-_3722189 | 2.12 |
ENSMUST00000102950.3
ENSMUST00000101632.3 |
Osbp2
|
oxysterol binding protein 2 |
chr9_-_45204083 | 2.10 |
ENSMUST00000034599.8
|
Tmprss4
|
transmembrane protease, serine 4 |
chr9_-_50561261 | 2.10 |
ENSMUST00000034568.5
|
Tex12
|
testis expressed gene 12 |
chr15_-_84105662 | 2.08 |
ENSMUST00000082365.5
|
Sult4a1
|
sulfotransferase family 4A, member 1 |
chr7_+_19228334 | 2.08 |
ENSMUST00000063976.8
|
Opa3
|
optic atrophy 3 |
chr13_-_64274879 | 2.07 |
ENSMUST00000109770.1
|
Cdc14b
|
CDC14 cell division cycle 14B |
chr15_+_9335550 | 2.05 |
ENSMUST00000072403.6
|
Ugt3a2
|
UDP glycosyltransferases 3 family, polypeptide A2 |
chr10_-_41709297 | 2.03 |
ENSMUST00000019955.9
ENSMUST00000099932.3 |
Ccdc162
|
coiled-coil domain containing 162 |
chr7_+_27119909 | 2.03 |
ENSMUST00000003100.8
|
Cyp2f2
|
cytochrome P450, family 2, subfamily f, polypeptide 2 |
chr8_+_19194319 | 2.01 |
ENSMUST00000052601.3
|
Defb14
|
defensin beta 14 |
chr4_+_62360695 | 2.01 |
ENSMUST00000084526.5
|
Slc31a1
|
solute carrier family 31, member 1 |
chr1_-_91413163 | 1.99 |
ENSMUST00000086851.1
|
Hes6
|
hairy and enhancer of split 6 |
chr19_-_40187277 | 1.99 |
ENSMUST00000051846.6
|
Cyp2c70
|
cytochrome P450, family 2, subfamily c, polypeptide 70 |
chr9_-_70141484 | 1.99 |
ENSMUST00000034749.8
|
Fam81a
|
family with sequence similarity 81, member A |
chr5_-_137149320 | 1.98 |
ENSMUST00000041226.8
|
Muc3
|
mucin 3, intestinal |
chr2_+_25700039 | 1.96 |
ENSMUST00000077667.3
|
Obp2a
|
odorant binding protein 2A |
chr2_+_58755177 | 1.96 |
ENSMUST00000102755.3
|
Upp2
|
uridine phosphorylase 2 |
chr18_-_46728342 | 1.96 |
ENSMUST00000035804.7
|
Cdo1
|
cysteine dioxygenase 1, cytosolic |
chr4_-_117133953 | 1.95 |
ENSMUST00000076859.5
|
Plk3
|
polo-like kinase 3 |
chr3_+_118562129 | 1.95 |
ENSMUST00000039177.7
|
Dpyd
|
dihydropyrimidine dehydrogenase |
chr2_+_155382186 | 1.95 |
ENSMUST00000134218.1
|
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr3_+_81999461 | 1.92 |
ENSMUST00000107736.1
|
Asic5
|
acid-sensing (proton-gated) ion channel family member 5 |
chr6_+_129533183 | 1.92 |
ENSMUST00000032264.6
|
Gabarapl1
|
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
chr5_-_146009598 | 1.91 |
ENSMUST00000138870.1
ENSMUST00000068317.6 |
Cyp3a25
|
cytochrome P450, family 3, subfamily a, polypeptide 25 |
chr3_+_89459325 | 1.91 |
ENSMUST00000107410.1
|
Pmvk
|
phosphomevalonate kinase |
chr14_+_66635251 | 1.89 |
ENSMUST00000159365.1
ENSMUST00000054661.1 ENSMUST00000159068.1 |
Adra1a
|
adrenergic receptor, alpha 1a |
chr3_+_94693556 | 1.88 |
ENSMUST00000090848.3
ENSMUST00000173981.1 ENSMUST00000173849.1 ENSMUST00000174223.1 |
Selenbp2
|
selenium binding protein 2 |
chrX_+_36598199 | 1.88 |
ENSMUST00000073339.6
|
Pgrmc1
|
progesterone receptor membrane component 1 |
chr18_-_35627223 | 1.86 |
ENSMUST00000025212.5
|
Slc23a1
|
solute carrier family 23 (nucleobase transporters), member 1 |
chr19_+_7494033 | 1.85 |
ENSMUST00000170373.1
|
Atl3
|
atlastin GTPase 3 |
chr2_-_126783416 | 1.85 |
ENSMUST00000130356.1
ENSMUST00000028842.2 |
Usp50
|
ubiquitin specific peptidase 50 |
chr1_-_180193653 | 1.84 |
ENSMUST00000159914.1
|
Adck3
|
aarF domain containing kinase 3 |
chr17_-_31637135 | 1.80 |
ENSMUST00000118504.1
ENSMUST00000078509.5 ENSMUST00000067801.6 |
Cbs
|
cystathionine beta-synthase |
chrX_-_38456407 | 1.79 |
ENSMUST00000074913.5
ENSMUST00000016678.7 ENSMUST00000061755.8 |
Lamp2
|
lysosomal-associated membrane protein 2 |
chr18_-_12860197 | 1.77 |
ENSMUST00000124570.1
|
Osbpl1a
|
oxysterol binding protein-like 1A |
chr14_-_51922773 | 1.75 |
ENSMUST00000089771.2
|
Rnase13
|
ribonuclease, RNase A family, 13 (non-active) |
chr2_-_48457245 | 1.74 |
ENSMUST00000127672.1
|
Gm13481
|
predicted gene 13481 |
chr3_+_89459118 | 1.72 |
ENSMUST00000029564.5
|
Pmvk
|
phosphomevalonate kinase |
chr4_-_108118504 | 1.72 |
ENSMUST00000149106.1
|
Scp2
|
sterol carrier protein 2, liver |
chr12_+_85288591 | 1.71 |
ENSMUST00000059341.4
|
Zc2hc1c
|
zinc finger, C2HC-type containing 1C |
chr7_+_26808880 | 1.70 |
ENSMUST00000040944.7
|
Cyp2g1
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
chr17_+_73107982 | 1.70 |
ENSMUST00000130574.1
ENSMUST00000149064.1 ENSMUST00000067545.6 |
Lclat1
|
lysocardiolipin acyltransferase 1 |
chr5_+_87000838 | 1.69 |
ENSMUST00000031186.7
|
Ugt2b35
|
UDP glucuronosyltransferase 2 family, polypeptide B35 |
chr5_+_125389284 | 1.69 |
ENSMUST00000100700.2
|
Gm10382
|
predicted gene 10382 |
chr7_-_25539845 | 1.67 |
ENSMUST00000066503.7
ENSMUST00000064862.6 |
Ceacam2
|
carcinoembryonic antigen-related cell adhesion molecule 2 |
chr2_+_58754910 | 1.66 |
ENSMUST00000059102.6
|
Upp2
|
uridine phosphorylase 2 |
chr4_-_149307506 | 1.64 |
ENSMUST00000055647.8
ENSMUST00000030806.5 ENSMUST00000060537.6 |
Kif1b
|
kinesin family member 1B |
chr15_+_10249560 | 1.63 |
ENSMUST00000134410.1
|
Prlr
|
prolactin receptor |
chr1_+_152399824 | 1.63 |
ENSMUST00000044311.8
|
Colgalt2
|
collagen beta(1-O)galactosyltransferase 2 |
chr17_+_24736639 | 1.62 |
ENSMUST00000115262.1
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr1_+_24678536 | 1.62 |
ENSMUST00000095062.3
|
Lmbrd1
|
LMBR1 domain containing 1 |
chr5_-_92505518 | 1.62 |
ENSMUST00000031377.7
|
Scarb2
|
scavenger receptor class B, member 2 |
chr2_-_38926217 | 1.61 |
ENSMUST00000076275.4
ENSMUST00000142130.1 |
Nr6a1
|
nuclear receptor subfamily 6, group A, member 1 |
chr1_+_4807823 | 1.61 |
ENSMUST00000027036.4
ENSMUST00000119612.2 ENSMUST00000137887.1 ENSMUST00000115529.1 ENSMUST00000150971.1 |
Lypla1
|
lysophospholipase 1 |
chr2_+_144556306 | 1.59 |
ENSMUST00000155876.1
ENSMUST00000149697.1 |
Sec23b
|
SEC23B (S. cerevisiae) |
chr14_+_55560904 | 1.59 |
ENSMUST00000072530.4
ENSMUST00000128490.1 |
Dcaf11
|
DDB1 and CUL4 associated factor 11 |
chr11_-_11898044 | 1.58 |
ENSMUST00000066237.3
|
Ddc
|
dopa decarboxylase |
chr15_+_25843264 | 1.57 |
ENSMUST00000022881.7
|
Fam134b
|
family with sequence similarity 134, member B |
chr1_-_121327776 | 1.57 |
ENSMUST00000160688.1
|
Insig2
|
insulin induced gene 2 |
chr5_-_145879857 | 1.57 |
ENSMUST00000035918.7
|
Cyp3a11
|
cytochrome P450, family 3, subfamily a, polypeptide 11 |
chr7_-_72306595 | 1.56 |
ENSMUST00000079323.5
|
Mctp2
|
multiple C2 domains, transmembrane 2 |
chrX_-_56598069 | 1.56 |
ENSMUST00000059899.2
|
Mmgt1
|
membrane magnesium transporter 1 |
chr17_+_36958571 | 1.56 |
ENSMUST00000040177.6
|
Znrd1as
|
Znrd1 antisense |
chr14_+_123659971 | 1.56 |
ENSMUST00000049681.7
|
Itgbl1
|
integrin, beta-like 1 |
chr3_-_107986408 | 1.55 |
ENSMUST00000012348.2
|
Gstm2
|
glutathione S-transferase, mu 2 |
chr5_-_45450143 | 1.55 |
ENSMUST00000154962.1
|
Qdpr
|
quinoid dihydropteridine reductase |
chrX_-_74023745 | 1.55 |
ENSMUST00000114353.3
ENSMUST00000101458.2 |
Irak1
|
interleukin-1 receptor-associated kinase 1 |
chr6_-_113531575 | 1.55 |
ENSMUST00000032425.5
|
Emc3
|
ER membrane protein complex subunit 3 |
chr8_+_123235086 | 1.54 |
ENSMUST00000181432.1
|
4933417D19Rik
|
RIKEN cDNA 4933417D19 gene |
chr3_-_146596588 | 1.54 |
ENSMUST00000029836.4
|
Dnase2b
|
deoxyribonuclease II beta |
chr13_+_8885937 | 1.52 |
ENSMUST00000177397.1
ENSMUST00000177400.1 ENSMUST00000177447.1 |
Idi1
|
isopentenyl-diphosphate delta isomerase |
chr11_-_11898092 | 1.52 |
ENSMUST00000178704.1
|
Ddc
|
dopa decarboxylase |
chr1_-_162866502 | 1.51 |
ENSMUST00000046049.7
|
Fmo1
|
flavin containing monooxygenase 1 |
chr7_+_68275970 | 1.51 |
ENSMUST00000153805.1
|
Fam169b
|
family with sequence similarity 169, member B |
chr11_-_50931612 | 1.51 |
ENSMUST00000109124.3
|
Zfp354b
|
zinc finger protein 354B |
chr5_-_45450121 | 1.51 |
ENSMUST00000127562.1
|
Qdpr
|
quinoid dihydropteridine reductase |
chr2_-_103485138 | 1.50 |
ENSMUST00000028610.3
|
Cat
|
catalase |
chr17_+_69969217 | 1.50 |
ENSMUST00000060072.5
|
Dlgap1
|
discs, large (Drosophila) homolog-associated protein 1 |
chr11_-_71019233 | 1.49 |
ENSMUST00000108523.3
ENSMUST00000143850.1 |
Derl2
|
Der1-like domain family, member 2 |
chr2_+_144556229 | 1.49 |
ENSMUST00000143573.1
ENSMUST00000028916.8 ENSMUST00000155258.1 |
Sec23b
|
SEC23B (S. cerevisiae) |
chr18_-_12819842 | 1.49 |
ENSMUST00000119043.1
|
Osbpl1a
|
oxysterol binding protein-like 1A |
chr8_-_93197799 | 1.49 |
ENSMUST00000034172.7
|
Ces1d
|
carboxylesterase 1D |
chr3_+_94342092 | 1.49 |
ENSMUST00000029794.5
|
Them5
|
thioesterase superfamily member 5 |
chr19_+_43838803 | 1.48 |
ENSMUST00000099413.2
|
Gm10768
|
predicted gene 10768 |
chr5_-_123182704 | 1.48 |
ENSMUST00000154713.1
ENSMUST00000031398.7 |
Hpd
|
4-hydroxyphenylpyruvic acid dioxygenase |
chr7_-_127946725 | 1.48 |
ENSMUST00000118755.1
ENSMUST00000094026.3 |
Prss36
|
protease, serine, 36 |
chr10_-_128673896 | 1.48 |
ENSMUST00000054764.7
|
Suox
|
sulfite oxidase |
chr17_+_34836987 | 1.47 |
ENSMUST00000173874.1
ENSMUST00000046244.8 ENSMUST00000180043.1 |
Dxo
|
decapping exoribonuclease |
chr10_-_41587753 | 1.47 |
ENSMUST00000160751.1
|
Ccdc162
|
coiled-coil domain containing 162 |
chr2_+_177508570 | 1.46 |
ENSMUST00000108940.2
|
Gm14403
|
predicted gene 14403 |
chr12_-_85288419 | 1.46 |
ENSMUST00000121930.1
|
Acyp1
|
acylphosphatase 1, erythrocyte (common) type |
chr7_+_119561699 | 1.46 |
ENSMUST00000167935.2
ENSMUST00000130583.1 |
Acsm2
|
acyl-CoA synthetase medium-chain family member 2 |
chr8_-_3748941 | 1.46 |
ENSMUST00000012847.1
|
Cd209a
|
CD209a antigen |
chr10_+_40629987 | 1.46 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr11_-_78165521 | 1.45 |
ENSMUST00000017530.3
|
Traf4
|
TNF receptor associated factor 4 |
chr2_-_32424005 | 1.44 |
ENSMUST00000113307.2
|
Slc25a25
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25 |
chr3_+_94398517 | 1.44 |
ENSMUST00000050975.3
|
Lingo4
|
leucine rich repeat and Ig domain containing 4 |
chr17_+_25875492 | 1.44 |
ENSMUST00000026827.8
ENSMUST00000169308.1 ENSMUST00000169085.1 ENSMUST00000163356.1 |
0610011F06Rik
|
RIKEN cDNA 0610011F06 gene |
chr1_-_121327672 | 1.43 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr8_-_93229517 | 1.42 |
ENSMUST00000176282.1
ENSMUST00000034173.7 |
Ces1e
|
carboxylesterase 1E |
chr13_+_21312198 | 1.42 |
ENSMUST00000004453.7
|
Gpx6
|
glutathione peroxidase 6 |
chr13_-_23761223 | 1.42 |
ENSMUST00000102964.2
|
Hist1h4a
|
histone cluster 1, H4a |
chr9_-_71168657 | 1.41 |
ENSMUST00000113570.1
|
Aqp9
|
aquaporin 9 |
chr10_+_4710119 | 1.41 |
ENSMUST00000105588.1
ENSMUST00000105589.1 |
Esr1
|
estrogen receptor 1 (alpha) |
chr17_+_84683131 | 1.40 |
ENSMUST00000171915.1
|
Abcg8
|
ATP-binding cassette, sub-family G (WHITE), member 8 |
chr19_-_11081088 | 1.40 |
ENSMUST00000025636.6
|
Ms4a8a
|
membrane-spanning 4-domains, subfamily A, member 8A |
chr11_+_115462464 | 1.40 |
ENSMUST00000106532.3
ENSMUST00000092445.5 ENSMUST00000153466.1 |
Slc16a5
|
solute carrier family 16 (monocarboxylic acid transporters), member 5 |
chr17_-_78985428 | 1.40 |
ENSMUST00000118991.1
|
Prkd3
|
protein kinase D3 |
chr10_+_34297421 | 1.39 |
ENSMUST00000047935.6
|
Tspyl4
|
TSPY-like 4 |
chr11_-_116189542 | 1.39 |
ENSMUST00000148601.1
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr10_+_87521795 | 1.39 |
ENSMUST00000020241.8
|
Pah
|
phenylalanine hydroxylase |
chr1_+_133363564 | 1.39 |
ENSMUST00000135222.2
|
Etnk2
|
ethanolamine kinase 2 |
chr8_-_27228581 | 1.39 |
ENSMUST00000121838.1
|
Adrb3
|
adrenergic receptor, beta 3 |
chr1_-_121332571 | 1.38 |
ENSMUST00000071064.6
|
Insig2
|
insulin induced gene 2 |
chr4_-_108118528 | 1.38 |
ENSMUST00000030340.8
|
Scp2
|
sterol carrier protein 2, liver |
chr17_-_31144271 | 1.38 |
ENSMUST00000024826.7
|
Tff2
|
trefoil factor 2 (spasmolytic protein 1) |
chr17_-_32420965 | 1.37 |
ENSMUST00000170392.1
|
Pglyrp2
|
peptidoglycan recognition protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 6.3 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
1.7 | 5.1 | GO:0051977 | lysophospholipid transport(GO:0051977) |
1.5 | 4.4 | GO:0070347 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
1.4 | 4.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
1.4 | 2.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.4 | 4.3 | GO:0006507 | GPI anchor release(GO:0006507) |
1.1 | 3.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
1.1 | 3.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.0 | 4.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.0 | 3.8 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.0 | 2.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.9 | 4.7 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.9 | 2.6 | GO:0006571 | tyrosine biosynthetic process(GO:0006571) aromatic amino acid family biosynthetic process(GO:0009073) aromatic amino acid family biosynthetic process, prephenate pathway(GO:0009095) |
0.9 | 2.6 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.8 | 2.5 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.8 | 2.4 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.8 | 3.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.8 | 2.3 | GO:1903918 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
0.8 | 3.1 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
0.8 | 4.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.8 | 0.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.7 | 2.2 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.7 | 2.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.7 | 3.6 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.7 | 2.8 | GO:0030091 | protein repair(GO:0030091) |
0.7 | 2.8 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.7 | 2.0 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.6 | 12.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.6 | 3.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.6 | 2.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.9 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.6 | 7.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.6 | 2.4 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.6 | 1.8 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.6 | 1.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.6 | 4.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.6 | 5.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.5 | 3.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.5 | 2.7 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.5 | 3.7 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 2.0 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.5 | 2.0 | GO:0042196 | chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
0.5 | 1.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.5 | 2.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.5 | 0.5 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.5 | 1.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.5 | 0.5 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.5 | 1.4 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.5 | 2.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.5 | 1.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.4 | 1.3 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.4 | 1.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.4 | 1.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.4 | 13.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 1.6 | GO:0016259 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
0.4 | 2.4 | GO:0090005 | protein depalmitoylation(GO:0002084) negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) macromolecule depalmitoylation(GO:0098734) |
0.4 | 2.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.4 | 1.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.4 | 2.4 | GO:0009074 | tryptophan catabolic process(GO:0006569) aromatic amino acid family catabolic process(GO:0009074) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.4 | 1.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.4 | 8.6 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.4 | 3.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.4 | 1.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.4 | 2.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.4 | 3.6 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.4 | 1.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.4 | 1.4 | GO:0015855 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.4 | 0.7 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.3 | 5.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 0.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.3 | 4.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.3 | 4.7 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.3 | 1.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 1.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.3 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.3 | 1.0 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.3 | 1.0 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.3 | 1.0 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 2.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.3 | 1.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 1.3 | GO:0002777 | antimicrobial peptide biosynthetic process(GO:0002777) antibacterial peptide biosynthetic process(GO:0002780) |
0.3 | 1.6 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 0.6 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 2.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.3 | 1.2 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.3 | 1.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.3 | 0.9 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.3 | 3.6 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.3 | 1.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 1.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.3 | 0.9 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.3 | 0.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 1.1 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 1.4 | GO:0060750 | prostate epithelial cord elongation(GO:0060523) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.3 | 1.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.3 | 2.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.3 | 0.8 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.3 | 1.4 | GO:0032827 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.3 | 3.8 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.3 | 1.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.3 | 0.8 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.3 | 3.7 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.3 | 0.8 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 7.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.3 | 1.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 0.3 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.3 | 1.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 1.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.3 | 0.8 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.3 | 1.0 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.3 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.3 | 2.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.2 | 2.0 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.2 | 2.2 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.7 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.2 | 1.0 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 0.5 | GO:0060266 | regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.2 | 2.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 2.4 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 6.0 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 3.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 2.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 1.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.9 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.2 | 0.7 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.2 | 1.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.9 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 1.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 0.7 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.2 | 2.7 | GO:0009650 | UV protection(GO:0009650) |
0.2 | 2.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 3.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.2 | 0.7 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 2.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 1.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 6.3 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.2 | 0.9 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.2 | 1.3 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.2 | 1.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 3.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.8 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.2 | 2.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 1.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 0.8 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.2 | 0.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.2 | 0.6 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.2 | 2.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.2 | 1.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.4 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) |
0.2 | 1.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 2.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.2 | 3.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 1.2 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
0.2 | 0.6 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 1.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.2 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 1.5 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.2 | 0.4 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.2 | 1.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.2 | 0.9 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.7 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 1.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.5 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.2 | 0.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.2 | 0.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.2 | 0.5 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.2 | 0.5 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
0.2 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 0.7 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.9 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.3 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.9 | GO:1904729 | regulation of intestinal lipid absorption(GO:1904729) |
0.2 | 1.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.2 | 1.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.3 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.5 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 0.5 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 1.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 1.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.2 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.2 | 0.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.2 | 0.5 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.2 | 1.3 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.6 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.2 | 0.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.3 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 1.7 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.2 | 0.2 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.2 | 0.9 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.2 | 0.6 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.3 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.2 | 2.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.2 | 1.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 2.0 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 1.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 2.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.7 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.1 | 1.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 2.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.4 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.6 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.4 | GO:0048352 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
0.1 | 0.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 1.5 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 1.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 0.4 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.1 | 0.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.1 | 0.9 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.5 | GO:0060376 | positive regulation of mast cell differentiation(GO:0060376) |
0.1 | 0.4 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.1 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.1 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.5 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 1.9 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 1.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.1 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 2.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.4 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.5 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 | 1.0 | GO:0006689 | ganglioside catabolic process(GO:0006689) oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.7 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 2.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
0.1 | 1.8 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 1.0 | GO:0072642 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 1.0 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.7 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.1 | 0.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 1.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.7 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 0.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 0.3 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
0.1 | 1.2 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.3 | GO:0016598 | protein arginylation(GO:0016598) |
0.1 | 0.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.7 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.1 | 0.3 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.1 | 3.1 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.2 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.4 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.1 | 0.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.1 | 0.3 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 1.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 2.3 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 1.8 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.7 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.1 | 2.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.1 | 0.9 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.8 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.1 | 1.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.2 | GO:1904717 | regulation of AMPA glutamate receptor clustering(GO:1904717) |
0.1 | 0.6 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 4.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 1.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 1.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.9 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 1.3 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 2.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.4 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.5 | GO:0097491 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 0.4 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.3 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 | 0.6 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 3.8 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.3 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.1 | 0.5 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.1 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 1.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 0.6 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.8 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 1.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.1 | 1.5 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.3 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.9 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.4 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.9 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.7 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.8 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.9 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.4 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 1.4 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.3 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.3 | GO:1902045 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.1 | 0.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.3 | GO:0033128 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.1 | 0.3 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.7 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 3.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.7 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.3 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.1 | 1.9 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.2 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
0.1 | 0.2 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.4 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 0.2 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 0.2 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 1.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 2.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.5 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.1 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 1.2 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 1.9 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.5 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.2 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.1 | 0.2 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 2.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.1 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.7 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 4.5 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.1 | 0.4 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.4 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.1 | 0.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 3.8 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.2 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 2.3 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.4 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 0.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.1 | 0.5 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 2.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.1 | 0.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.3 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 0.9 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.1 | 0.3 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.9 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.1 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.5 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 1.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.1 | 0.6 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
0.1 | 0.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 1.0 | GO:0099563 | modification of synaptic structure(GO:0099563) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.2 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) monocyte homeostasis(GO:0035702) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.1 | 0.2 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.3 | GO:1904937 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.1 | 0.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.3 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.1 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.1 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.7 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 1.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.4 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.6 | GO:0046959 | habituation(GO:0046959) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.2 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.7 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.5 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.6 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.6 | GO:0036296 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) |
0.1 | 0.7 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.2 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.9 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 2.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 1.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.6 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.2 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.1 | 2.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.3 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.1 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.0 | 1.9 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 1.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.4 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.0 | 0.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.0 | 0.5 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.5 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.0 | 0.2 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.0 | 0.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.0 | 0.3 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.5 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.0 | 0.7 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.5 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.3 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.3 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.6 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 1.0 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.0 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 1.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 4.4 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
0.0 | 1.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.2 | GO:0021756 | striatum development(GO:0021756) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.3 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.0 | 0.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.0 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 1.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.3 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 0.5 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.5 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.4 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 1.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0034776 | response to histamine(GO:0034776) |
0.0 | 0.2 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.0 | 0.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 0.1 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.0 | 0.4 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0015881 | creatine transport(GO:0015881) |